Reducing Multi-Cycle Reviews Is FDA Priority

Reducing Multi-Cycle Reviews Is FDA Priority
FDA Commissioner Mark McClellan today described key steps the agency is taking to shorten drug approval times, in his keynote speech at IIR�s Phases conference in Washington, D.C.


Comments are closed.

Do NOT follow this link or you will be banned from the site!
%d bloggers like this: